FIELD: diagnostics.
SUBSTANCE: invention relates to a kit for predicting or diagnosing the risk of developing a disease, a method for providing information for predicting or diagnosing the risk of developing a disease, a method of screening a therapeutic agent for a disease, and a pharmaceutical composition for preventing or providing therapeutic treatment on a disease, in particular non-alcoholic fatty liver disease. In particular, by means of the predictive or diagnostic kit according to the present invention, the degree of risk of developing non-alcoholic fatty liver disease can be effectively predicted or diagnosed, in particular, the predictive value and the value of the information provided in non-obese subjects are excellent. Therefore, it can be effectively used to prevent or provide therapeutic treatment of corresponding disease, obtaining effective information about non-alcoholic fatty liver disease.
EFFECT: pharmaceutical composition for preventing or providing therapeutic treatment according to the invention can be effectively used for the treatment of non-alcoholic fatty liver disease.
6 cl, 13 dwg, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2798723C1 |
METHOD FOR PREDICTION OF HEPATOTROPHIC THERAPY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2015 |
|
RU2595827C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2013 |
|
RU2537229C1 |
COMPOSITION AND METHOD OF PREVENTION, REMOVAL OF SYMPTOMS OR THERAPEUTIC EFFECT ON LIVER DAMAGE | 2020 |
|
RU2810601C2 |
METHOD OF DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN METABOLIC SYNDROME | 2022 |
|
RU2803945C1 |
METHOD FOR PREDICTING THE RISK OF LIVER FIBROSIS IN PATIENTS WITH OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2794862C1 |
METHOD FOR PREDICTION OF PROGRESSIVE CLINICAL COURSE OF EARLY FORMS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2768466C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
Authors
Dates
2023-07-18—Published
2020-07-30—Filed